ftc-istock-530746621-rivernorthphotography
RiverNorthPhotography / iStockphoto.com
1 June 2017Americas

FTC would ‘eviscerate’ attorney-client privilege, says Boehringer

The Federal Trade Commission’s (FTC) attempt to obtain Boehringer Ingelheim’s documents relating to a patent dispute settlement would “eviscerate attorney-client privilege”, Boehringer told a US court on Friday, May 26.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
6 June 2017   The US Chamber of Commerce and the Association of Corporate Counsel have filed an amicus curiae brief in support of Boehringer Ingelheim Pharmaceuticals in its dispute with the Federal Trade Commission.

More on this story

Americas
6 June 2017   The US Chamber of Commerce and the Association of Corporate Counsel have filed an amicus curiae brief in support of Boehringer Ingelheim Pharmaceuticals in its dispute with the Federal Trade Commission.

More on this story

Americas
6 June 2017   The US Chamber of Commerce and the Association of Corporate Counsel have filed an amicus curiae brief in support of Boehringer Ingelheim Pharmaceuticals in its dispute with the Federal Trade Commission.